Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 10/20 | 0.53 |
| ▸ | MC4R | P32245 | 2/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31184496 | 1.00 | KISS1R (0.53) | KISS1RMC4RACE | |
| SCHEMBL29476104 | 1.00 | KISS1R (0.53) | KISS1RMC4RACE | |
| SCHEMBL29476415 | 1.00 | KISS1R (0.53) | KISS1RMC4RACE | |
| SCHEMBL29511055 | 1.00 | KISS1R (0.53) | KISS1RMC4RACE | |
| SCHEMBL30276243 | 0.97 | MC4R (0.53) | KISS1RMC4RACE | |
| SCHEMBL29511018 | 0.96 | KISS1R (0.58) | KISS1RACE | |
| SCHEMBL29511037 | 0.96 | KISS1R (0.58) | KISS1RACE | |
| SCHEMBL30166970 | 0.95 | MC4R (0.56) | KISS1RMC4R | |
| SCHEMBL31249518 | 0.95 | MC4R (0.55) | KISS1RMC4R | |
| SCHEMBL31249537 | 0.95 | MC4R (0.55) | KISS1RMC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554607-A2 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | Rhythm Pharmaceuticals, Inc. (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2024015880-A2 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | RHYTHM PHARMACEUTICALS, INC. (US) | 2024-01-18 | — | — | WO | claimed |
| EP-4711004-A2 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS | Rhythm Pharmaceuticals, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4554607-A2 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | Rhythm Pharmaceuticals, Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024015880-A2 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | RHYTHM PHARMACEUTICALS, INC. (US) | 2024-01-18 | — | — | WO | disclosed |